A detailed history of Tower Research Capital LLC (Trc) transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 256 shares of TMDX stock, worth $16,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares
256
Previous 4,948 94.83%
Holding current value
$16,038
Previous $745,000 94.63%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $636,610 - $826,308
-4,692 Reduced 94.83%
256 $40,000
Q2 2024

Aug 13, 2024

BUY
$72.62 - $150.62 $326,862 - $677,940
4,501 Added 1006.94%
4,948 $745,000
Q1 2024

May 15, 2024

SELL
$70.86 - $89.93 $434,796 - $551,810
-6,136 Reduced 93.21%
447 $33,000
Q4 2023

Feb 13, 2024

BUY
$36.74 - $81.08 $114,077 - $251,753
3,105 Added 89.28%
6,583 $519,000
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $138,808 - $249,397
2,596 Added 294.33%
3,478 $190,000
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $19,140 - $25,642
289 Added 48.74%
882 $74,000
Q1 2023

May 09, 2023

SELL
$53.63 - $82.33 $214,251 - $328,908
-3,995 Reduced 87.07%
593 $45,000
Q4 2022

Feb 10, 2023

BUY
$39.08 - $64.29 $77,573 - $127,615
1,985 Added 76.26%
4,588 $283,000
Q3 2022

Nov 10, 2022

BUY
$31.56 - $55.75 $45,698 - $80,726
1,448 Added 125.37%
2,603 $109,000
Q2 2022

Aug 15, 2022

BUY
$20.56 - $32.15 $16,776 - $26,234
816 Added 240.71%
1,155 $36,000
Q1 2022

May 12, 2022

SELL
$12.58 - $26.94 $23,184 - $49,650
-1,843 Reduced 84.46%
339 $9,000
Q4 2021

Feb 14, 2022

BUY
$19.16 - $32.68 $34,028 - $58,039
1,776 Added 437.44%
2,182 $41,000
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $83,617 - $111,329
-3,226 Reduced 88.82%
406 $13,000
Q2 2021

Aug 16, 2021

SELL
$21.63 - $40.07 $28,400 - $52,611
-1,313 Reduced 26.55%
3,632 $121,000
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $47,871 - $128,970
2,697 Added 119.97%
4,945 $206,000
Q4 2020

Feb 16, 2021

SELL
$11.91 - $19.9 $226,135 - $377,841
-18,987 Reduced 89.41%
2,248 $45,000
Q3 2020

Nov 16, 2020

BUY
$13.78 - $18.84 $238,931 - $326,666
17,339 Added 445.05%
21,235 $293,000
Q2 2020

Aug 13, 2020

BUY
$11.66 - $18.26 $5,993 - $9,385
514 Added 15.2%
3,896 $70,000
Q1 2020

May 15, 2020

BUY
$10.5 - $20.2 $29,442 - $56,640
2,804 Added 485.12%
3,382 $41,000
Q4 2019

Feb 07, 2020

SELL
$16.61 - $21.64 $53,550 - $69,767
-3,224 Reduced 84.8%
578 $11,000
Q3 2019

Nov 05, 2019

SELL
$20.27 - $28.93 $55,722 - $79,528
-2,749 Reduced 41.96%
3,802 $90,000
Q2 2019

Aug 13, 2019

BUY
$22.36 - $30.41 $146,480 - $199,215
6,551 New
6,551 $190,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.99B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.